TīmeklisWe plan to provide updates as EZH-1501 reaches key enrollment milestones and we plan to provide preliminary data from EZH-1501 in the second half of 2024. On March 1, 2024, we announced a pipeline reprioritization. Given the breadth of our current tazemetostat clinical development program, we have discontinued enrollment in our … Tīmeklis2024. gada 2. marts · During the fourth quarter, the company initiated a phase Ib/II basket study, EZH-1501, to evaluate the safety and efficacy of tazemetostat across …
Epizyme Reports Second Quarter 2024 Financial Results and …
Tīmeklis2024. gada 1. marts · We plan to provide updates on EZH-1501, as it treats key enrollment milestones. We also plan to provide preliminary data from EZH-1501 in the second half of 2024. Additionally, as Grant mentioned ... Tīmeklis2024. gada 1. marts · Initiated Phase 1b/2 tazemetostat hematological basket study (EZH-1501): During the fourth quarter of 2024, Epizyme initiated EZH-1501, its … bowling paderborn
Epizyme Reports Fourth Quarter and Full Year 2024 Financial
Tīmeklis2024. gada 11. maijs · EPZM initiated a phase Ib/II basket study, ARIA (EZH-1501), during fourth-quarter 2024 to evaluate the safety and efficacy of tazemetostat across multiple new types of hematological malignancies. Tīmeklis2024. gada 2. marts · During the fourth quarter, the company initiated a phase Ib/II basket study, EZH-1501, to evaluate the safety and efficacy of tazemetostat across … Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: During the fourth quarter of 2024, Epizyme initiated two basket studies – … bowling oxford mississippi